Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Anteris Technologies Global Corp.

Get SEC filing alerts via email and in your feed for Anteris Technologies Global Corp.

AVR

Anteris Technologies Global Corp.

About Anteris Technologies Global Corp.

Anteris Technologies is a medical device company specializing in innovative transcatheter aortic valve replacement (TAVR) systems. Its flagship product, DurAVR, features a biomimetic, single-piece design with proprietary ADAPT tissue technology for enhanced durability and hemodynamics. The company targets the global cardiovascular market, focusing on treating aortic stenosis with minimally invasive solutions that aim to improve patient outcomes and valve longevity.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Anteris Technologies Global Corp.

1
1
Anteris Technologies Global Corp. Anteris Technologies Reports Q1 2026 Financial Results with $494.6M in Net Sales and $22.9M Net Loss

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
Anteris Technologies Global Corp. Anteris Technologies Reports $1.9 Million in Net Sales for 2025, Operating Loss Increases to $93.9 Million

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Anteris Technologies Global Corp. Anteris Technologies Reports 73% Decline in Q3 Revenue, Operating Loss Increases

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Anteris Technologies Global Corp. Anteris Technologies Reports Decrease in Revenue and Increased Losses for Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Anteris Technologies Global Corp. Anteris Technologies Reports $21.9 Million Net Loss and Decreased Revenue in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments